PAEDIATRIC HEALTH · KASDAP HEALTHCARE
Children are not small adults. Paediatric pharmacotherapy requires age-appropriate dosing, formulations, and safety profiles that differ fundamentally from adult medicine — a critical consideration for every healthcare professional managing children's health.
Why Paediatric Pharmacotherapy Is Unique
The pharmacokinetics and pharmacodynamics of medicines in children differ substantially from adults, and vary further across different paediatric age groups — neonates (0–28 days), infants (1–12 months), toddlers (1–3 years), young children (3–12 years), and adolescents (12–18 years). Drug absorption, distribution, metabolism, and excretion all change with age, body composition, and organ maturation.
Hepatic enzyme systems responsible for drug metabolism are immature at birth and develop at different rates. Renal function reaches adult levels only by 1–2 years of age. These differences mean that adult doses cannot simply be scaled down by body weight — specialised paediatric dosing calculations and formulations are required.
Key Paediatric Medicine Categories
Antipyretics and Analgesics
Fever management is one of the most common paediatric prescribing challenges. Paracetamol (10–15 mg/kg every 4–6 hours) is the gold standard antipyretic and analgesic in children of all ages. Available as syrups, drops, suppositories, and dispersible tablets, the formulation choice depends on the child's age and clinical condition.
Ibuprofen is an effective alternative from 6 months of age, offering anti-inflammatory benefits useful in conditions like otitis media. It should be avoided in children with dehydration, renal impairment, or chickenpox. Aspirin is contraindicated in children under 16 due to the risk of Reye's syndrome.
Oral Rehydration Therapy: Saving Lives Simply
Diarrhoeal disease remains a leading cause of child mortality in India. WHO-formulated Oral Rehydration Salts (ORS) combined with zinc supplementation is the evidence-based cornerstone of diarrhoea management in children. Zinc (20 mg/day for 10–14 days in children over 6 months) reduces diarrhoea duration and severity and prevents recurrence.
Antibiotics in Paediatric Practice
Amoxicillin remains the first-line antibiotic for most common paediatric bacterial infections including pneumonia, otitis media, and sinusitis. Azithromycin is preferred for atypical pneumonia and pertussis. Co-amoxiclav is used for resistant infections. Paediatric antibiotic syrups must be reconstituted correctly and stored appropriately to maintain stability.
Antiepileptic Drugs in Children
Epilepsy is one of the most common neurological conditions in Indian children. Valproate is effective across multiple seizure types but carries teratogenic risk and requires monitoring for hepatotoxicity. Levetiracetam has become increasingly preferred in paediatric epilepsy due to its favourable tolerability and minimal drug interactions. Phenobarbitone, though older, remains widely used in resource-limited settings due to its low cost and efficacy.
Nutritional Deficiency Management
Iron deficiency anaemia affects over 60% of Indian children under 5. The National Iron Plus Initiative recommends iron supplementation for all children 6–59 months. Iron polymaltose complex (IPC) syrups are preferred over ferrous sulphate in young children for better GI tolerability. Vitamin D supplementation (400–1000 IU/day) is recommended for all breastfed infants. Vitamin A supplementation under the National Programme reduces child mortality from measles and diarrhoea.
Respiratory Medicines in Children
Salbutamol nebulisation and MDI with spacer are the primary rescue therapies in paediatric asthma. Budesonide Respules (nebulisation solution) provide effective inhaled corticosteroid therapy for young children unable to use dry powder inhalers. Bronchiolitis in infants, caused predominantly by Respiratory Syncytial Virus (RSV), is managed supportively — bronchodilators have limited evidence in RSV bronchiolitis.
Formulation Considerations in Paediatric Medicine
Age-appropriate formulations are as important as correct drug selection. Key considerations include: syrups and drops for infants, dispersible tablets for toddlers who cannot swallow capsules, and the sugar content of syrups in children with dental concerns or diabetes. Excipients that are safe in adults may be harmful to neonates — benzyl alcohol preservative is contraindicated in neonates due to gasping syndrome risk.
Kasdap Healthcare's Paediatric Range
Kasdap Healthcare provides a comprehensive paediatric portfolio including antipyretics, ORS, antibiotics, nutritional supplements, and respiratory medicines in age-appropriate formulations — all manufactured under WHO-GMP aligned standards for consistent quality across every dose.
Explore our complete pharmaceutical portfolio
